T1	Participants 52 107	children and adolescents with autism spectrum disorders
T2	Participants 862 1164	METHOD In a quasi-randomized trial over the course of âˆ¼ 18 months, 58 of 210 families with children with autism spectrum disorders participating in a larger study of phenotypic and genotypic factors reported significant concerns about blood draws and elected to use the Blood Draw Intervention Program.
